Skip to content
MedsAcross

Medicine

Piperacillin and Tazobactam 12 g/1.5 g per 100 mL powder for injection

Piperacillin and Tazobactam · Intravenous, parenteral
Available on requestPrescription onlyUS FDAGeneric name

Piperacillin and Tazobactam 12 g/1.5 g per 100 mL powder for injection is a generic prescription medicine for intravenous, parenteral use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Supplied as 1 pharmacy bulk package bottle per box – NDC 0781-3180-94…

Key facts

Active ingredient (INN)
Piperacillin and Tazobactam
Brand
Sold under the generic name
Strength
12 g/1.5 g per 100 mL
Dosage form
Powder for injection
Route
Intravenous, parenteral
Origin register
US FDA, United States
Storage
Supplied as 1 pharmacy bulk package bottle per box – NDC 0781-3180-94 Piperacillin and tazobactam for injection, USP pharmacy bulk bottles should be stored at 20° to 25°C (68° to 77°F) prior to reconstitution.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.10Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
29 October 2014
Identifiers
RxCUI 312447DailyMed set ID b1cb1314-d3e0-4b44-a1df-de14c32e8cc6NDC 0781-3117Application ANDA203557

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
1 vial, pharmacy bulk package in 1 carton / 51 mL in 1 vial, pharmacy bulk package55150-474-01—12 October 2023

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 22 October 1993Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Piperacillin and Tazobactam 12 g/1.5 g per 100 mL powder for injection.

Compare 1

Other strengths and forms of Piperacillin and Tazobactam

Clinical summary

Piperacillin and Tazobactam is a fixed-dose combination of a penicillin-class antibacterial and a beta lactamase inhibitor indicated for the treatment of intra-abdominal infections in adult and pediatric patients 2 months of age and older. MedsAcross supplies Piperacillin and Tazobactam for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Piperacillin and Tazobactam

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Piperacillin and Tazobactam 12 g/1.5 g per 100 mL powder for injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.